Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    15908661 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Pancreas Cancer: Molecular Profiling as a Guide to Therapy Before and After Surgery ("Personalized Medicine")
Condition: Pancreatic Adenocarcinoma
Interventions: Drug: Targeted chemotherapy prior to surgery;   Drug: standard FOLFIRINOX chemotherapy prior to surgery;   Drug: Gemcitabine after surgery;   Other: No additional therapy after surgery;   Drug: Targeted chemotherapy after surgery;   Radiation: Chemoradiotherapy (cXRT)
2 Unknown  Gemcitabine With or Without Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Unresectable Pancreatic Adenocarcinoma
Condition: Pancreatic Cancer
Interventions: Drug: gemcitabine hydrochloride;   Drug: oxaliplatin

Indicates status has not been verified in more than two years